Figure 2: Ticagrelor Reduces Platelet–Leukocyte Aggregates

The percentage of leukocytes with attached platelets for each subject is plotted at baseline (BL) and at 24 h in patients given placebo (A, open circles) and ticagrelor (A, filled circles). A significant difference between groups on the change from baseline to 24 h is indicated by an asterisk. Delta change of platelet–leukocyte aggregates at 24 h (compared with baseline) is represented for patients randomized to placebo (B, open circles and top dashed line) and ticagrelor (B, filled circles and bottom dashed line).



Elsevier user license